PatientIQ Raises $30M Series C+ to Expand EHR-Integrated Patient Outcomes Platform

PatientIQ Secures $30M Series C+

PatientIQ, a Chicago-based healthcare technology company, has raised $30 million in Series C+ funding. The round was announced on September 3, 2026. No lead investor was disclosed, and no additional investors were listed in the funding details.

What PatientIQ Does

Founded in 2016, PatientIQ provides an EHR-integrated platform that helps health systems, specialty clinics, and medical device and life science companies collect and analyze patient-reported outcomes at scale. Its product suite includes ClinicalPRO, ResearchPRO, and DataPRO, which turn outcomes data into benchmarks, registry submissions, and research datasets for quality improvement, regulatory reporting, and evidence generation.

Platform Reach

Per company announcements, the PatientIQ platform is used by more than 750 healthcare organizations. In January 2026, the company announced a partnership with Zimmer Biomet integrating its mymobility and ZBEdge analytics through PatientIQ.

Why This Round Matters

The Series C+ extends PatientIQ's runway as demand for structured patient-reported outcomes data continues to grow across health systems, device makers, and life science companies. The platform's position between EHR systems and specialty care workflows gives it a data asset that supports both quality improvement and regulatory-grade evidence generation.

Acquisition Angle

PatientIQ operates in a strategically valuable niche: outcomes data infrastructure that connects providers, medical device manufacturers, and life science research. Strategic acquirers in healthcare IT, EHR platforms, and medical device analytics could view the company's installed base of more than 750 organizations and its device-industry partnerships as attractive distribution and data assets. The Zimmer Biomet partnership illustrates how device makers can embed PatientIQ's analytics into their own digital health offerings, a model that may appeal to larger medtech or health data platforms seeking outcomes measurement capabilities.

Key Facts

• Company: PatientIQ
• Headquarters: Chicago
• Founded: 2016
• Products: ClinicalPRO, ResearchPRO, DataPRO
• Round: Series C+
• Amount: US$30,000,000
• Date: September 3, 2026
• Lead Investor: Not disclosed
• Investors: Not disclosed
• Platform Reach: More than 750 healthcare organizations
• Notable Partnership: January 2026 partnership with Zimmer Biomet integrating mymobility and ZBEdge analytics through PatientIQ